Style
orforglipron UK
Jul
Orforglipron UK: Is It Available Yet? Full 2026 Timeline Explained
No. As of July 2026, orforglipron is not approved, licensed, or legally available in the UK. It has been approved in the United States, and UK regulatory review is underway, but there is no confirmed date for UK access yet.
This article explains exactly where things stand, why the delay exists, and what the realistic timeline looks like.
What Is Orforglipron?
Orforglipron is a once-daily oral GLP-1 receptor agonist developed by Eli Lilly, sold in the US under the brand name Foundayo. It belongs to the same drug class as Mounjaro (tirzepatide) and Wegovy (semaglutide), which mimic a natural gut hormone that regulates appetite and blood sugar.
The key difference is chemical structure. Mounjaro and Wegovy are peptides — large, protein-based molecules that must be injected because they’d otherwise be broken down by digestion. Orforglipron is a small molecule, meaning it survives the digestive tract and can be taken as a simple tablet — with no fasting requirement, unlike the oral semaglutide pill.
Is Orforglipron Approved in the UK?
No. Orforglipron has not received a UK marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA).
| Region | Status | Date |
|---|---|---|
| United States (FDA) | Approved (brand name Foundayo) | 1 April 2026 |
| United Kingdom (MHRA) | Under review, not yet approved | Submission expected mid-2026 |
| NHS (England) | Separate NICE appraisal in progress | Appraisal GID-TA11650 |
Eli Lilly has submitted orforglipron for approval in more than 40 countries and plans to launch in each market following clearance, but each country’s regulator conducts its own independent review.
Why the Delay?
UK approval and US approval aren’t the same process. The MHRA reviews safety and efficacy data independently, though its International Recognition Procedure can sometimes shorten review times by drawing on work already completed by trusted regulators like the FDA. A standard MHRA review takes roughly 150–210 days from submission.
Even after MHRA approval, that only permits private prescribing. Separately, the National Institute for Health and Care Excellence (NICE) must assess cost-effectiveness before the NHS can fund it — a process that typically adds months on top of MHRA approval.
Expected UK Timeline
- MHRA submission: expected mid-2026
- Private prescription availability: possible from late 2026, if the MHRA review goes smoothly
- NHS availability: unlikely before 2027 at the earliest, pending a positive NICE recommendation
These dates are industry estimates based on Eli Lilly’s public statements and typical regulatory timelines — not confirmed launch dates.
Can I Buy Orforglipron in the UK Right Now?
No, not legally. Any online provider claiming to sell or import orforglipron/Foundayo into the UK ahead of MHRA approval is operating outside UK medicines regulation. Because it hasn’t been reviewed by the MHRA, there’s no independent verification of manufacturing standards, dosing, or safety for a product obtained this way.
How Does It Compare to Mounjaro and Wegovy?
In Eli Lilly’s ATTAIN-2 phase 3 trial, participants on the highest orforglipron dose lost an average of around 12.4% of body weight over 72 weeks. That’s a meaningful result, but injectable tirzepatide (Mounjaro) has shown higher average weight loss in comparable trials. For UK patients who can tolerate self-injection, MHRA-approved injectable options remain available now through regulated pharmacies, while orforglipron remains a future option.
Frequently Asked Questions orforglipron UK
Is Foundayo the same as orforglipron uk? Yes. Foundayo is the US brand name for orforglipron.
When will orforglipron be available in the UK? There’s no confirmed date. Private prescribing could begin as early as late 2026 if MHRA review proceeds smoothly; NHS access is unlikely before 2027.
Is orforglipron a peptide like Mounjaro? No. It’s a small-molecule drug, not a peptide, which is why it can be taken as a tablet rather than an injection.
Can I import Foundayo from the US myself? Importing prescription-only medicines for personal use without UK authorisation carries legal and safety risks, and any UK supply must go through MHRA-approved channels.
